{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:10:08Z","timestamp":1794276608033,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40249-018-0491-7","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T06:36:36Z","timestamp":1539930996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Treatment outcomes of visceral leishmaniasis in Ethiopia from 2001 to 2017: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-4553","authenticated-orcid":false,"given":"Eyob Alemayehu","family":"Gebreyohannes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya Srikanth","family":"Bhagvathula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadesse Melaku","family":"Abegaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Assen","family":"Seid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,19]]},"reference":[{"issue":"11","key":"491_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrmicro1748","volume":"5","author":"F Chappuis","year":"2007","unstructured":"Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873\u201382.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"491_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P Desjeux","year":"2004","unstructured":"Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305\u201318.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"7","key":"491_CR3","doi-asserted-by":"publisher","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","volume":"8","author":"PJ Hotez","year":"2014","unstructured":"Hotez PJ, Alvarado M, Bas\u00e1\u00f1ez M-G, Bolliger I, Bourne R, Boussinesq M, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014;8(7):e2865.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"491_CR4","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1371\/journal.pntd.0000412","volume":"3","author":"PJ Hotez","year":"2009","unstructured":"Hotez PJ, Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis. 2009;3(8):e412.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"491_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1179\/000349809X12554106963555","volume":"103","author":"A Hailu","year":"2009","unstructured":"Hailu A, Gramiccia M, Kager P. Visceral leishmaniasis in aba-Roba, South\u2013Western Ethiopia: prevalence and incidence of active and subclinical infections. Ann Trop Med Parasitol. 2009;103(8):659\u201370.","journal-title":"Ann Trop Med Parasitol"},{"issue":"9","key":"491_CR6","doi-asserted-by":"publisher","first-page":"e3131","DOI":"10.1371\/journal.pntd.0003131","volume":"8","author":"S Leta","year":"2014","unstructured":"Leta S, Dao THT, Mesele F, Alemayehu G. Visceral leishmaniasis in Ethiopia: an evolving disease. PLoS Negl Trop Dis. 2014;8(9):e3131.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"491_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","volume":"22","author":"J Alvar","year":"2006","unstructured":"Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Paraitol. 2006;22(12):552\u20137.","journal-title":"Trends Paraitol"},{"issue":"2","key":"491_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","volume":"26","author":"J van Griensven","year":"2012","unstructured":"van Griensven J, Diro E. Visceral leishmaniasis. Infect Dis Clin N Am. 2012;26(2):309\u201322.","journal-title":"Infect Dis Clin N Am"},{"issue":"10","key":"491_CR9","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1371\/journal.pntd.0000313","volume":"2","author":"C Bern","year":"2008","unstructured":"Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis. 2008;2(10):e313.","journal-title":"PLoS Negl Trop Dis"},{"key":"491_CR10","volume-title":"Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. Geneva, Switzerland: World Health Organization, 2010 22\u201326 March; 2010. Report No.: Contract No.: 949"},{"key":"491_CR11","first-page":"147","volume-title":"Ethiopia Standard Treatment Guidelines for General Hospital","author":"Food Medicine and Healthcare Administration and Control Authority of Ethiopia","year":"2014","unstructured":"Food Medicine and Healthcare Administration and Control Authority of Ethiopia. Ethiopia Standard Treatment Guidelines for General Hospital; 2014. p. 147\u201350."},{"issue":"6","key":"491_CR12","doi-asserted-by":"publisher","first-page":"e2869","DOI":"10.1371\/journal.pntd.0002869","volume":"8","author":"E Diro","year":"2014","unstructured":"Diro E, Lynen L, Ritmeijer K, Boelaert M, Hailu A, van Griensven J. Visceral leishmaniasis and HIV coinfection in East Africa. PLoS Negl Trop Dis. 2014;8(6):e2869.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"491_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/cid\/civ530","volume":"61","author":"R Mahajan","year":"2015","unstructured":"Mahajan R, Das P, Isaakidis P, Sunyoto T, Sagili KD, Lima MA, et al. Combination treatment for visceral leishmaniasis patients coinfected with human immunodeficiency virus in India. Clin Infect Dis. 2015;61(8):1255\u201362.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"491_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-016-0112-2","volume":"5","author":"OP Singh","year":"2016","unstructured":"Singh OP, Singh B, Chakravarty J, Sundar S. Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective. Infect Dis Poverty. 2016;5(1):1.","journal-title":"Infect Dis Poverty"},{"issue":"4","key":"491_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"issue":"4","key":"491_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ypmed.2007.08.012","volume":"45","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007;45(4):247\u201351.","journal-title":"Prev Med"},{"issue":"2","key":"491_CR17","first-page":"1377","volume":"11","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Wang C, Pang X, Li F, Chen W, Tan W. Antibiotics are not beneficial in the management of category III prostatitis: a meta-analysis. Urol J. 2014;11(2):1377.","journal-title":"Urol J"},{"issue":"8","key":"491_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1046\/j.1365-3156.2003.01088.x","volume":"8","author":"S Lyons","year":"2003","unstructured":"Lyons S, Veeken H, Long J. Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop Med Int Health. 2003;8(8):733\u20139.","journal-title":"Trop Med Int Health"},{"issue":"7","key":"491_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4314\/eamj.v83i7.9451","volume":"83","author":"T Haile","year":"2006","unstructured":"Haile T, Anderson S. Visceral leishmaniasis in northern Ethiopia. East Afr Med J. 2006;83(7):389.","journal-title":"East Afr Med J"},{"issue":"3","key":"491_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4269\/ajtmh.2009.81.373","volume":"81","author":"M Herrero","year":"2009","unstructured":"Herrero M, Orfanos G, Argaw D, Mulugeta A, Aparicio P, Parre\u00f1o F, Bernal O, Rubens D, Pedraza J, Lima MA, Flevaud L. Natural history of a visceral leishmaniasis outbreak in highland Ethiopia. Am J Trop Med Hyg. 2009;81(3):373\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"491_CR21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1365-3156.2010.02550.x","volume":"15","author":"Z Hurissa","year":"2010","unstructured":"Hurissa Z, Gebre-Silassie S, Hailu W, Tefera T, Lalloo DG, Cuevas LE, et al. Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in Northwest Ethiopia. Trop Med Int Health. 2010;15(7):848\u201355.","journal-title":"Trop Med Int Health"},{"issue":"12","key":"491_CR22","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1093\/cid\/cir674","volume":"53","author":"K Ritmeijer","year":"2011","unstructured":"Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, Collin SM, et al. Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. Clin Infect Dis. 2011;53(12):e152\u2013e8.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"491_CR23","doi-asserted-by":"publisher","first-page":"e2875","DOI":"10.1371\/journal.pntd.0002875","volume":"8","author":"E Diro","year":"2014","unstructured":"Diro E, Lynen L, Mohammed R, Boelaert M, Hailu A, van Griensven J. High parasitological failure rate of visceral leishmaniasis to sodium Stibogluconate among HIV co-infected adults in Ethiopia. PLoS Negl Trop Dis. 2014;8(5):e2875.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"491_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/tmi.12407","volume":"20","author":"E Diro","year":"2015","unstructured":"Diro E, Lynen L, Gebregziabiher B, Assefa A, Lakew W, Belew Z, et al. Clinical aspects of paediatric visceral leishmaniasis in north-West Ethiopia. Trop Med Int Health. 2015;20(1):8\u201316.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"491_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12879-016-1746-1","volume":"16","author":"A Tamiru","year":"2016","unstructured":"Tamiru A, Tigabu B, Yifru S, Diro E, Hailu A. Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, north-West Ethiopia. BMC Infect Dis. 2016;16(1):548.","journal-title":"BMC Infect Dis"},{"key":"491_CR26","doi-asserted-by":"publisher","first-page":"e2017001","DOI":"10.4178\/epih.e2017001","volume":"39","author":"GM Welay","year":"2017","unstructured":"Welay GM, Alene KA, Dachew BA. Visceral leishmaniasis treatment outcome and its determinants in Northwest Ethiopia. Epidemiol Health. 2017;39:e2017001.","journal-title":"Epidemiol Health."},{"issue":"3","key":"491_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40261-016-0481-0","volume":"37","author":"R Kimutai","year":"2017","unstructured":"Kimutai R, Musa AM, Njoroge S, Omollo R, Alves F, Hailu A, Khalil EA, Diro E, Soipei P, Musa B, Salman K. Safety and effectiveness of sodium stibogluconate and paromomycin combination for the treatment of visceral leishmaniasis in eastern Africa: results from a pharmacovigilance programme. Clin Drug Investig. 2017;37(3):259\u201372.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"491_CR28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","volume":"95","author":"K Ritmeijer","year":"2001","unstructured":"Ritmeijer K, Veeken H, Melaku Y, Leal G, Amsalu R, Seaman J, et al. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Trans R Soc Trop Med Hyg. 2001;95(6):668\u201372.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"491_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1086\/505217","volume":"43","author":"K Ritmeijer","year":"2006","unstructured":"Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, Boots G, et al. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Clin Infect Dis. 2006;43(3):357\u201364.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"491_CR30","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.trstmh.2010.07.007","volume":"104","author":"W Hailu","year":"2010","unstructured":"Hailu W, Weldegebreal T, Hurissa Z, Tafes H, Omollo R, Yifru S, et al. Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection. Trans R Soc Trop Med Hyg. 2010;104(11):706\u201312.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"491_CR31","doi-asserted-by":"publisher","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","volume":"4","author":"A Hailu","year":"2010","unstructured":"Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, et al. Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Negl Trop Dis. 2010;4(10):e709.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"491_CR32","doi-asserted-by":"publisher","first-page":"e2613","DOI":"10.1371\/journal.pntd.0002613","volume":"8","author":"EA Khalil","year":"2014","unstructured":"Khalil EA, Weldegebreal T, Younis BM, Omollo R, Musa AM, Hailu W, et al. Safety and efficacy of single dose versus multiple doses of AmBisome\u00ae for treatment of visceral leishmaniasis in eastern Africa: a randomised trial. PLoS Negl Trop Dis. 2014;8(1):e2613.","journal-title":"PLoS Negl Trop Dis"},{"key":"491_CR33","volume-title":"Control of the leishmaniasis: report of a meeting of the WHO expert committee on the control of Leishmaniases, Geneva, 22\u201326 March 2010","author":"World Health Organization (WHO)","year":"2010","unstructured":"World Health Organization (WHO). Control of the leishmaniasis: report of a meeting of the WHO expert committee on the control of Leishmaniases, Geneva, 22\u201326 March 2010. Geneva, Switzerland: WHO; 2010."},{"key":"491_CR34","first-page":"16","volume":"18","author":"J Olobo-Okao","year":"2014","unstructured":"Olobo-Okao J, Sagaki P. Leishmaniasis in Uganda: historical account and a review of the literature. Pan Afr Med J. 2014;18:16.","journal-title":"Pan Afr Med J"},{"issue":"6","key":"491_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cmi.2017.11.008","volume":"24","author":"C Rodrigo","year":"2017","unstructured":"Rodrigo C, Weeratunga P, Fernando SD, Rajapakse S. Amphotericin B for treatment of visceral leishmaniasis; a systematic review and meta-analysis of prospective, comparative clinical studies including dose ranging studies. Clin Microbiol Infect. 2017;24(6):591\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"491_CR36","first-page":"32","volume":"18","author":"B Monge-Maillo","year":"2016","unstructured":"Monge-Maillo B, Lopez-Velez R. Treatment options for visceral leishmaniasis and HIV coinfection. AIDS Rev. 2016;18(1):32\u201343.","journal-title":"AIDS Rev"},{"issue":"3","key":"491_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/trstmh\/trx023","volume":"111","author":"EM Aderie","year":"2017","unstructured":"Aderie EM, Diro E, Zachariah R, da Fonseca MS, Abongomera C, Dolamo BL, Ritmeijer K. Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia? Trans R Soc Trop Med Hyg. 2017;111(3):107\u201316.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"491_CR38","doi-asserted-by":"publisher","first-page":"e3053","DOI":"10.1371\/journal.pntd.0003053","volume":"8","author":"S Burza","year":"2014","unstructured":"Burza S, Mahajan R, Sinha PK, van Griensven J, Pandey K, Lima MA, Sanz MG, Sunyoto T, Kumar S, Mitra G, Kumar R. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome). PLoS Negl Trop Dis. 2014;8(8):e3053.","journal-title":"PLoS Negl Trop Dis"},{"issue":"26","key":"491_CR39","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","volume":"34","author":"PM Gillespie","year":"2016","unstructured":"Gillespie PM, Beaumier CM, Strych U, Hayward T, Hotez PJ, Bottazzi ME. Status of vaccine research and development of vaccines for leishmaniasis. Vaccine. 2016;34(26):2992\u20135.","journal-title":"Vaccine"},{"issue":"3\u20134","key":"491_CR40","first-page":"98","volume":"3","author":"S Sundar","year":"2016","unstructured":"Sundar S, Singh A. Recent developments and future prospects in the treatment of visceral leishmaniasis. Ther Adv Infect Dis. 2016;3(3\u20134):98\u2013109.","journal-title":"Ther Adv Infect Dis"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-018-0491-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40249-018-0491-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-018-0491-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T19:25:07Z","timestamp":1571426707000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-018-0491-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,19]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1186\/s40249-018-0491-7","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,19]]},"assertion":[{"value":"29 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eyob Alemayehu Gebreyohannes, lecturer of clinical pharmacy, department of clinical pharmacy, University of Gondar, email: justeyob@gmail.com; Akshaya Srikanth Bhagvathula, assistant professor of clinical pharmacy, department of clinical pharmacy, University of Gondar, email: akshaypharmd@gmail.com; Tadesse Melaku Abegaz, lecturer of clinical pharmacy, department of clinical pharmacy, University of Gondar, email: abegaztadesse981@gmail.com; Mohammed Assen Seid, lecturer of clinical pharmacy, department of clinical pharmacy, University of Gondar, email: hassenm100@gmail.com.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"This study was carried out in strict accordance with the recommendations in the PRISMA guidelines. Ethics committee or institutional review board permission was not required since it is systematic review and meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}